We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.42B
1-Year Est. Return
34.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.43%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$587M
AUM Growth
-$12.4M
(-2.1%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AST
Asterias Biotherapeutics Inc. Series A
AST
|
+$9.59M |
| 2 |
STAAR Surgical
STAA
|
+$6.49M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.14% |
| 2 | Consumer Staples | 36.5% |
Similar funds
PTC
NI
CBA
KC
EWS
IHG
SCM
PPC
Broadwood Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Broadwood Capital held 6 positions worth $587M, down 2.1% from $600M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 59% a quarter earlier, followed by Consumer Staples.
- Broadwood Capital added most to Asterias Biotherapeutics Inc. Series A in Q2 2015, an estimated $9.59M increase.
- Broadwood Capital's ten largest holdings make up 100% of its $587M portfolio in Q2 2015.
- Broadwood Capital opened 0 new positions and closed 0 in Q2 2015.
- Broadwood Capital's portfolio value fell 2.1% quarter-over-quarter to $587M.
Based on Broadwood Capital's 13F filing for Q2 2015, filed 14 Aug 2015.